Literature DB >> 32255912

Pilot study investigating the feasibility of mitral valve repair without aortic cross-clamping and cardioplegia.

Wanda J Gordon-Evans1, John P Carney1, Mathew T Lahti1, Richard W Bianco1.   

Abstract

There is evidence that perfusing the heart with a heart and lung machine is less injurious than cross-clamping the aorta and administering cardioplegia during cardiac surgery. Although mitral valve replacement has been carried out without aortic cross-clamping and cardioplegia, it has been stated that cross-clamping is necessary in order to maintain visualization and a motionless surgical field for mitral valve repair. The purpose of this study was to determine the surgical feasibility of mitral valve repair without cross-clamping the aorta and using cardioplegia. Our hypothesis was that a completely bloodless and motion-free field would not be necessary to carry out mitral valve repair with annuloplasty and synthetic chordae tendineae sutures. Papillary muscles, chordae tendineae, annulus, and mitral valve leaflets were all readily visualized. Chordae tendineae sutures were used and annuloplasty was conducted without visual obstruction or motion interference. Our results show that mitral valve repair is feasible without cross-clamping the aorta and using cardioplegia. Copyright and/or publishing rights held by the Canadian Veterinary Medical Association.

Entities:  

Mesh:

Year:  2020        PMID: 32255912      PMCID: PMC7088510     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  17 in total

Review 1.  Mitral valve repair in dogs.

Authors:  Masami Uechi
Journal:  J Vet Cardiol       Date:  2012-02-25       Impact factor: 1.701

Review 2.  Historical review, epidemiology and natural history of degenerative mitral valve disease.

Authors:  Michele Borgarelli; James W Buchanan
Journal:  J Vet Cardiol       Date:  2012-03-03       Impact factor: 1.701

3.  Cross-clamp time is an independent predictor of mortality and morbidity in low- and high-risk cardiac patients.

Authors:  Nael Al-Sarraf; Lukman Thalib; Anne Hughes; Maighread Houlihan; Michael Tolan; Vincent Young; Eillish McGovern
Journal:  Int J Surg       Date:  2010-10-20       Impact factor: 6.071

4.  On-pump beating-heart versus conventional coronary artery bypass grafting for revascularization in patients with severe left ventricular dysfunction: early outcomes.

Authors:  Bilgehan Erkut; Ozgur Dag; Mehmet Ali Kaygin; Mutlu Senocak; Husnu Kamil Limandal; Umit Arslan; Adem Kiymaz; Ahmet Aydin; Nail Kahraman; Eyup Serhat Calik
Journal:  Can J Surg       Date:  2013-12       Impact factor: 2.089

5.  The effect of benazepril on survival times and clinical signs of dogs with congestive heart failure: Results of a multicenter, prospective, randomized, double-blinded, placebo-controlled, long-term clinical trial.

Authors: 
Journal:  J Vet Cardiol       Date:  1999-05       Impact factor: 1.701

6.  Evaluation of techniques and outcomes of mitral valve repair in dogs.

Authors:  Leigh G Griffiths; E Christopher Orton; June A Boon
Journal:  J Am Vet Med Assoc       Date:  2004-06-15       Impact factor: 1.936

7.  Long-term evaluation of prosthetic mitral valves in sheep.

Authors:  E Irwin; G Lang; R Clack; J St Cyr; W Runge; J Foker; R Bianco
Journal:  J Invest Surg       Date:  1993 Mar-Apr       Impact factor: 2.533

Review 8.  Timing surgery in mitral regurgitation: defining risk and optimising intervention using stress echocardiography.

Authors:  Boyang Liu; Nicola C Edwards; Simon Ray; Richard P Steeds
Journal:  Echo Res Pract       Date:  2016-10-13

9.  Efficacy and safety of beating heart mitral valve replacement.

Authors:  Mohd Lateef Wani; Abdul Gani Ahangar; Shyam Singh; Ifat Irshad; Nayeem Ul-Hassan; Shadab Nabi Wani; Farooq Ahmad Ganie; Mohd Akbar Bhat
Journal:  Int Cardiovasc Res J       Date:  2014-04-01

10.  Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Preclinical Myxomatous Mitral Valve Disease Receiving Pimobendan or Placebo: The EPIC Study.

Authors:  A Boswood; S G Gordon; J Häggström; G Wess; R L Stepien; M A Oyama; B W Keene; J Bonagura; K A MacDonald; M Patteson; S Smith; P R Fox; K Sanderson; R Woolley; V Szatmári; P Menaut; W M Church; M L O'Sullivan; J-P Jaudon; J-G Kresken; J Rush; K A Barrett; S L Rosenthal; A B Saunders; I Ljungvall; M Deinert; E Bomassi; A H Estrada; M J Fernandez Del Palacio; N S Moise; J A Abbott; Y Fujii; A Spier; M W Luethy; R A Santilli; M Uechi; A Tidholm; C Schummer; P Watson
Journal:  J Vet Intern Med       Date:  2017-12-06       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.